Home / Biotechnology

Global Nano-drug Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19520632 | Published Date: 16-Nov-2021 | No. of pages: 125

Description

Nanoscale materials are used as a means of diagnostic tools or to deliver therapeutic agents to specific target sites in a controlled manner.
The Nano-drug market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Nano-drug market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Nano-drug Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Nano-drug market are:
Samyang Biopharm
Celgene
Selecta Biosciences
Lummy
GlaxoSmithKline
Abbott
Kaken Pharmaceutical
Kadmon Pharmaceuticals
Roche
Stryker
Gilead Sciences
Mitsubishi Pharma
Merck
Novavax
Par Pharmaceutical
Sanofi
Novartis
OSI Pharmaceuticals
Johnson＆Johnson
Cerulean Pharma
Navidea Biopharmaceuticals
Pfizer
Eli Lilly
Astrazeneca

Most important types of Nano-drug products covered in this report are:
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension

Most widely used downstream fields of Nano-drug market covered in this report are:
Cancer and Tumors
Autoimmune Disorders
Heart Disease

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.